Clinical Trials Directory

Trials / Unknown

UnknownNCT03248336

Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children

Objective Assessment of Disparity Vergence After Treatment of Symptomatic Convergence Insufficiency (CI) in Children

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Salus University · Academic / Other
Sex
All
Age
9 Years – 17 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate changes in objective measures of disparity vergence after office-based vergence/accommodative therapy (OBVAT) for convergence insufficiency (CI) in children 12-17 years old.

Detailed description

30 participants with normal binocular vision and 30 with CI will be recruited for this prospective study. All participants with CI will be treated with 12 weeks of office-based vergence/accommodative therapy. The primary outcome measure will be the average peak velocity for 4° symmetrical convergence steps. Other objective outcome measures of disparity vergence will be time to peak velocity, latency, and accuracy. Changes in clinical measures \[near point of convergence (NPC), positive fusional vergence at near (PFV)\] and symptoms will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREoffice-based vergence/accommodative therapyone -to-one treatment by a trained therapists. The subject is asked to perform 5-6 therapy procedures during a 60 minute therapy session. The subject is also asked to perform 15 minutes per day of home-based therapy.

Timeline

Start date
2018-09-02
Primary completion
2022-09-01
Completion
2022-12-01
First posted
2017-08-14
Last updated
2020-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03248336. Inclusion in this directory is not an endorsement.